Search filters

List of works by Irina Kiseleva

A Phase 1 Randomized Placebo-Controlled Study to Assess the Safety, Immunogenicity and Genetic Stability of a New Potential Pandemic H7N9 Live Attenuated Influenza Vaccine in Healthy Adults

scientific article published on 10 June 2020

Anti-Influenza Effect of Nanosilver in a Mouse Model

scientific article published on 13 November 2020

Application of real time RT-PCR for the genetic homogeneity and stability tests of the seed candidates for live attenuated influenza vaccine production

scientific article

Assessment of human immune responses to H7 avian influenza virus of pandemic potential: results from a placebo-controlled, randomized double-blind phase I study of live attenuated H7N3 influenza vaccine.

scientific article

COVID-19 Shuts Doors to Flu but Keeps Them Open to Rhinoviruses

scientific article published in 2021

COVID-19 in Light of Seasonal Respiratory Infections

scientific article published on 20 August 2020

Cell-based assay for the determination of temperature sensitive and cold adapted phenotypes of influenza viruses.

scientific article published on March 2004

Clinical testing of pre-pandemic live attenuated A/H5N2 influenza candidate vaccine in adult volunteers: results from a placebo-controlled, randomized double-blind phase I study.

scientific article

Contribution of neuraminidase of influenza viruses to the sensitivity to sera inhibitors and reassortment efficiency

scientific article published on 11 July 2014

Cross-Protective Efficacy of Monovalent Live Influenza B Vaccines against Genetically Different Lineages of B/Victoria and B/Yamagata in Ferrets

scientific article published on 30 August 2018

Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories.

scientific article

Development of live cultural pandemic influenza vaccine Vector-Flu

scientific article

Development of one-step real-time PCR assay for titrating trivalent live attenuated influenza vaccines

scientific article published in January 2014

Evaluation in Mouse Model of Combined Virus-bacterial Vaccine Based on Attenuated Influenza A(H7N3) Virus and the Group B Streptococcus Recombinant Polypeptides

scientific article published on 31 October 2016

Evaluation of A(H1N1)pdm09 LAIV vaccine candidates stability and replication efficiency in primary human nasal epithelial cells

scientific article published on 19 June 2019

Evaluation of a candidate live attenuated influenza vaccine prepared in Changchun BCHT (China) for safety and efficacy in ferrets

scientific article published on 26 October 2016

Generation of influenza transfectants using purified recombinant nucleocapsid protein

scientific article published on 01 December 1998

Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2).

scientific article published on 18 February 2011

Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses.

scientific article

H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers.

scientific article

H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial.

scientific article

Implementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor viruses

scientific article published on 28 October 2015

Interferon and other proinflamatory cytokine responses in vitro following infection with wild-type and cold-adapted reassortant influenza viruses.

scientific article published on 13 June 2006

Live Attenuated Influenza H7N3 Vaccine is Safe, Immunogenic and Confers Protection in Animal Models.

scientific article

Live attenuated pandemic influenza vaccine: clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries.

scientific article

New Points of Departure for More Global Influenza Vaccine Use

scientific article published on 23 July 2020

Non-Mouse-Adapted H1N1pdm09 Virus as a Model for Influenza Research

scientific article published on 29 May 2020

Nucleotide sequences of the neuraminidase genes of influenza A/Leningrad/134/57 (H2N2) virus and two of its live, attenuated, cold-adapted variants.

scientific article published in January 1995

PB2 and PA genes control the expression of the temperature-sensitive phenotype of cold-adapted B/USSR/60/69 influenza master donor virus

article

Phenotypic and genetic analyses of the heterogeneous population present in the cold-adapted master donor strain: A/Leningrad/134/17/57 (H2N2).

scientific article published on June 2004

Phenotypic characteristics of novel swine-origin influenza A/California/07/2009 (H1N1) virus

scientific article

Possible outcomes of reassortment in vivo between wild type and live attenuated influenza vaccine strains

scientific article

Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants

scientific article published on October 2004

Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model

scientific article published in PLoS ONE

Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge

scientific article published on 08 July 2019

[Peculiarity of reassortment of current wild type influenza viruses with master donor viruses for live influenza vaccine].

scientific article